Results 1-20 of 37 for cervical segment:7113182

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Seamus McCarthy: Those 12% would be 144 cases, so effectively there are 1,056 women who developed cervical cancer who had engaged with cervical screening. That 12% can be forgotten about. They had not been engaging with cervical screening.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

...the first chief executive of the National Cancer Screening Service board. That board was created to continue with BreastCheck, to seek to roll out what had been a fledgling, regionally-based Irish cervical cancer screening programme from about 1996, which had not rolled out at that point, and to begin the investigative process around the development of BowelScreen. At the time I was very...

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Dr. Tony Holohan: I would not have believed that to be an isolated incident where there would be a discordance in reporting in respect of a case of cervical cancer in retrospect. That is a feature of cervical screening programmes around the world-----

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Tony O'Brien: Let me revert to where we started our short discussion. The cervical screening programme is designed to detect early cell changes, which can lead to further investigation. There is no-----

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Tony O'Brien: Let me tell the Deputy something that he is unwilling to hear. Ten or 12 years ago when this country embarked on the process of introducing a cervical screening programme, it was known, because it was known everywhere, that that programme would not be infallible.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Bobby Aylward: I understand the cervical screening programme was originally rolled out in 2008. Was the witness part of setting up the original screening programme?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Ciarán Breen: Do the Deputies mean our interaction with cervical screening?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Catherine Connolly: Does Dr. Holohan regard what has happened with cervical smears as a serious incident?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Ciarán Breen: We have 11 relating to the national cervical cancer screening service. In three of them, we have been given an indemnity by the laboratory concerned.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Ms Ann Duffy: There was nothing specific to cervical services.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Jonathan O'Brien: I might come back to this issue later. There are 11 cases relating to cervical care. Mr. Breen said there were four claims relating to the breast cancer screening programme.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Jonathan O'Brien: Can Mr. Breen say if the four screening services have similar results to those of cervical checks, in terms of false negatives or misdiagnosis etc?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

David Cullinane: I understand that there are two types of cervical cancer. We have been through this.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Catherine Murphy: Would the witness read that in both respects, or would he only read it in the context of the cervical screening service?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Jim Breslin: To be complete, and we are trying to do this in real time, the other feature that is mentioned later on is that 12% of the cases were for women with no cervical screening history so we may have to take out 12% of the 1,200 as well.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Tony O'Brien: No. We do not have quite that process anymore. The cervical cancer screening service moved back into the cancer control programme earlier this year. We gave the person a different role. Even were that person to be in the same role, the director would not continue to have this responsibility.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

.... I do not wish to overindulge. As the Secretary General stated, we are happy to stay for as long as it takes to give members whatever information we can. Technically, there are two types of cervical cancer. One causes 90% of------

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Tony O'Brien: The Deputy is not following the logic. There is no cervical screening programme or any population-based cancer screening programme in the world that can guarantee that there will not subsequently be a cancer. Neither can it guarantee that, in a test that is not fool-proof, there will be no abnormalities missed.

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Catherine Murphy: I wish to ask about the incident that is very current at the moment, namely, that relating to cervical smear tests. Within that €2.2 billion, would the State Claims Agency have captured an amount that would be part of a contingent liability specifically relating to the failure that we are seeing at the moment?

Public Accounts Committee: State Claims, Management of Legal Costs and Policy on Open Disclosure
Implications of CervicalCheck Revelations
2016 Financial Statements of the State Claims Agency
2016 Financial Statements of the HSE (10 May 2018)

Mr. Ciarán Breen: When we looked at them in terms of the periods of time that they cover, from 2014 up to 2018, there were different years involved. In a cervical smear situation, one would expect to see some claims arise from misdiagnosis. That is something one would expect and certainly looking at the numbers, we did not see a pattern here.